# Larimar Therapeutics, Inc.: Form DEF 14A, filed May 4, 2016

- Company: [Larimar Therapeutics, Inc.](/companies/lrmr.md) (CIK 1374690)
- Form: DEF 14A
- Filed: 2016-05-04
- Accepted by EDGAR: May 4, 2016, 17:23 ET
- Period: 2016-06-30
- Accession: 0001193125-16-577958
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1374690/000119312516577958/d113014ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374690/000119312516577958/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1374690/000119312516577958/d113014ddef14a.htm

Filed May 4, 2016.
Source: SEC EDGAR, the filing index for accession 0001193125-16-577958. Last ingested by Listed: Nov 13, 2026, 17:49 ET. No prices; not investment advice.
